Drug Research
Scope & Guideline
Advancing the Frontiers of Pharmacology
Introduction
Aims and Scopes
- Pharmacological Studies:
Research on the pharmacodynamics and pharmacokinetics of various drugs, including their mechanisms of action and therapeutic effects across different conditions. - Drug Development and Formulation:
Exploration of novel drug formulations, including nanoparticles, liposomes, and other delivery systems to enhance drug efficacy and minimize side effects. - Clinical and Preclinical Research:
Investigation of drug efficacy and safety through clinical trials, observational studies, and preclinical animal models. - Toxicology and Safety Assessment:
Examination of drug-induced toxicity and adverse effects, focusing on mechanisms of toxicity and strategies for mitigating risks. - Repurposing Existing Drugs:
Research aimed at identifying new therapeutic uses for established medications, enhancing their utility in treating various conditions. - Natural Products and Phytochemistry:
Investigation of the pharmacological properties of natural compounds and their potential applications in drug development. - Artificial Intelligence and Computational Drug Discovery:
Utilization of AI and computational methods for drug discovery, including molecular docking and virtual screening techniques.
Trending and Emerging
- Artificial Intelligence in Drug Discovery:
A growing trend is the application of AI and machine learning techniques in drug discovery and development, enabling more efficient identification of potential drug candidates and predictive modeling of drug interactions. - Investigations into COVID-19 Treatments:
Research focused on therapeutic strategies for COVID-19 has surged, with numerous studies evaluating existing drugs and novel compounds for their efficacy against the virus. - Nanomedicine and Targeted Delivery Systems:
There is an increasing emphasis on nanotechnology in drug delivery, exploring how nanoparticles can enhance the bioavailability and targeted delivery of therapeutic agents. - Drug Repurposing Strategies:
Repurposing existing drugs for new therapeutic indications has gained traction, particularly in the context of urgent health crises, allowing rapid deployment of effective treatments. - Neuropharmacology and Neurodegenerative Disorders:
Research on pharmacological interventions for neurodegenerative diseases, including Alzheimer's and Parkinson's disease, is on the rise, reflecting the pressing need for effective therapies in this area.
Declining or Waning
- Gastrointestinal Drug Development:
While there has been significant interest in gastrointestinal diseases, the specific focus on drug therapy for these conditions has diminished, possibly due to emerging therapies targeting other systems or diseases. - Traditional Herbal Medicine:
Although historically significant, the exploration of traditional herbal medicines as standalone treatments has decreased, likely as a result of a growing emphasis on scientifically validated pharmaceuticals. - Viral Hepatitis Research:
Research specifically focused on viral hepatitis has seen a reduction in publications, potentially overshadowed by the urgency of research related to COVID-19 and other emerging infectious diseases. - Conventional Drug Delivery Systems:
Interest in conventional drug delivery methods has waned in favor of more innovative and advanced delivery systems, such as nanotechnology-based approaches. - Basic Pharmacology of Established Drugs:
The basic pharmacological studies of well-established drugs are less frequently published, as researchers are increasingly focused on novel compounds and mechanisms.
Similar Journals
ACTA PHARMACEUTICA
Connecting scholars and practitioners with cutting-edge insights.ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.
CURRENT TOPICS IN MEDICINAL CHEMISTRY
Empowering Researchers with Cutting-Edge InsightsCURRENT TOPICS IN MEDICINAL CHEMISTRY is a prestigious journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of medicinal chemistry through the dissemination of high-quality research from 2001 to 2024. With an ISSN of 1568-0266 and an E-ISSN of 1873-4294, this journal is recognized for its significant contributions, as evidenced by its Scopus ranking in the 63rd percentile in the category of Drug Discovery, specifically at position #58 out of 157. Currently placed in Quartile 3 within Drug Discovery and Quartile 2 in miscellaneous medicine as of 2023, it serves as an essential resource for researchers, professionals, and students interested in the latest developments, methodologies, and applications in medicinal chemistry. The journal aims to foster collaboration and innovation by featuring original research articles, reviews, and brief communications that address current and emerging challenges in the discipline. Although it is not an open access platform, the journal's rich content is indispensable for those striving to enhance therapeutic strategies and drug development processes.
Iranian Journal of Pharmaceutical Research
Championing excellence in pharmacological research and discovery.Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.
Bangladesh Journal of Pharmacology
Bridging Research and Practice in PharmacologyThe Bangladesh Journal of Pharmacology, published by the Bangladesh Pharmacological Society, is a leading platform dedicated to advancing knowledge in the field of pharmacology. With an ISSN of 1991-007X and an E-ISSN of 1991-0088, this open access journal has been making significant contributions to the field since its inception in 2006. Located at the Bangabandhu Sheikh Mujib Medical University in Dhaka, Bangladesh, the journal provides a vital resource for researchers, professionals, and students interested in pharmacology, toxicology, and pharmaceutics. As of 2023, the journal is categorized in the Q4 quartile for pharmacology, ranking 240th out of 313 in Scopus and falling within the 23rd percentile, reflecting its commitment to the dissemination of high-quality research. The journal encompasses a diverse array of topics from basic research to clinical applications, aiming to foster a deeper understanding of pharmacological principles and practices. By providing open access to its content, the Bangladesh Journal of Pharmacology ensures that valuable scientific findings are readily available to the global community, supporting the advancement of medical and pharmaceutical sciences.
BMC Pharmacology & Toxicology
Empowering discoveries in drug interactions and safety.Welcome to BMC Pharmacology & Toxicology, a premier open-access journal dedicated to advancing the fields of pharmacology and toxicology. Published by BMC since 2012, this esteemed journal offers a platform for researchers, professionals, and students to disseminate cutting-edge research and innovative findings that explore the intricate interactions between drugs and biological systems. With its robust Q2 ranking in both general medicine and pharmacology categories for 2023, BMC Pharmacology & Toxicology is recognized for its significant contributions to the academic community, reflected in its strategic positioning within the 61st and 49th percentiles in Scopus rankings for related disciplines. The journal's commitment to open access ensures that vital research is accessible to a global audience, fostering collaboration and informed discussions. We invite you to engage with the latest studies, reviews, and innovative methodologies that shape the future of pharmacological and toxicological sciences.
Journal of Pharmacological Sciences
Empowering health through cutting-edge pharmacological insights.Journal of Pharmacological Sciences is a leading peer-reviewed academic journal dedicated to the field of pharmacology, published by the Japanese Pharmacological Society. Since its inception, this journal has offered an essential platform for the dissemination of high-quality research, contributing significantly to advancements in molecular medicine and pharmacology. With an impact factor that places it in the prestigious Q2 quartile for both categories, the journal has established itself as a credible source of innovative findings and methodologies since its transition to Open Access in 2015. This accessibility enables a broader audience, including researchers, healthcare professionals, and students, to engage with valuable insights and discussions pertinent to drug development, pharmacodynamics, and therapeutic strategies. Based in Kyoto, Japan, the journal serves as a vital resource for the global pharmacological community, encouraging collaboration and research that leads to improved health outcomes. For more information, submissions, and access to the latest research, visit the journal’s website.
DARU-Journal of Pharmaceutical Sciences
Elevating the discourse in drug discovery and pharmacology.DARU-Journal of Pharmaceutical Sciences is a leading peer-reviewed journal published by SPRINGER INT PUBL AG that focuses on the dynamic and rapidly evolving fields of pharmaceutical sciences, including drug discovery, pharmacology, and toxicology. With an impressive Q2 ranking in both Drug Discovery and Miscellaneous Medicine categories for 2023, this journal stands out as a vital resource for researchers, professionals, and students alike, offering a platform for significant contributions to the scientific community. Covering a comprehensive scope from 2000 to 2024 and indexed by Scopus, the journal ranks within the top percentile in its field, with a ranking of #66/313 in Pharmacology and #34/157 in Drug Discovery, reaffirming its impact and relevance. The journal promotes open access to foster widespread dissemination of knowledge in pharmaceutical sciences, ultimately aiming to bridge the gap between research and clinical applications. For those looking to stay at the forefront of pharmaceutical innovation, DARU represents an invaluable connection to the latest studies and breakthrough findings.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Unveiling Innovations in Drug Action and TherapeuticsNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is a prestigious journal published by SPRINGER, focusing on the dynamic fields of pharmacology and toxicology. With an ISSN of 0028-1298 and an E-ISSN of 1432-1912, this esteemed publication has been a staple in the scientific community since its inception in 1969, continuing to wield influence with a convergence of research that reaches through 2024. Ranked in the Q2 category for both medicine and pharmacology, it stands at an impressive 111th out of 313 in the Scopus rankings for pharmacology, reflecting its significant impact in the field. Though not offering open access, the journal remains a vital resource for researchers, professionals, and students seeking to explore groundbreaking studies and advancements in pharmacological science. With its high standards and comprehensive coverage, NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is essential reading for those dedicated to understanding the mechanisms of drug action and the complexities of therapeutic interventions.
INDIAN JOURNAL OF PHARMACOLOGY
Innovating drug action insights to enhance therapeutic practices.INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.
Acta Pharmaceutica Sinica B
Pioneering Innovations in Drug DevelopmentActa Pharmaceutica Sinica B is a prestigious open access journal that has been setting the standard in the field of pharmacology, toxicology, and pharmaceutics since its establishment in 2011. Published by the Institute of Materia Medica, Chinese Academy of Medical Sciences, the journal serves as a vital platform for researchers, professionals, and students seeking to disseminate innovative findings in drug development, pharmaceutical sciences, and therapeutic applications. With an impressive impact factor reflecting its high academic quality, Acta Pharmaceutica Sinica B has achieved Q1 status in the category of Pharmacology, Toxicology and Pharmaceutics as of 2023, ranking #1 out of 80 journals in General Pharmacology. This journal not only focuses on the latest advancements in drug research and formulation but also emphasizes interdisciplinary approaches, fostering collaborations that span various scientific domains. The accessible nature of the journal, combined with its rigorous peer-review process, ensures that crucial insights and breakthroughs reach a global audience swiftly and effectively. For those looking to stay at the forefront of pharmaceutical research, Acta Pharmaceutica Sinica B is an indispensable resource.